|
Q3 FY2026
As of Dec 31, 2025
|
Q2 FY2026
As of Sep 30, 2025
|
Q1 FY2026
As of Jun 30, 2025
|
Q4 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|
| ASSETS | ||||
| CURRENT | ||||
| Cash and restricted cash | ||||
| Accounts receivable | ||||
| Deferred financing costs | ||||
| Work in progress | ||||
| Tax receivable | ||||
| Prepaid expenses | ||||
| Total current assets | ||||
| Due from related parties | ||||
| Equipment | ||||
| TOTAL ASSETS | ||||
| LIABILITIES | ||||
| CURRENT | ||||
| Accounts payable | ||||
| Accrued liabilities | ||||
| Deferred grant | ||||
| Deferred revenue | ||||
| Provision for legal claim | ||||
| Convertible debentures | ||||
| Restricted share unit liability | ||||
| Total current liabilities | ||||
| Loans payable | ||||
| TOTAL LIABILITIES | ||||
| SHAREHOLDERS’ DEFICIENCY | ||||
| Class A Subordinate Voting Shares, without par value: unlimited authorized; 12,618,775 and 7,825,571 issued and outstanding, respectively | ||||
| Class A Subordinate Voting Shares | ||||
| Total class A Subordinate Voting Shares, without par value: unlimited authorized; 12,618,775 and 7,825,571 issued and outstanding, respectively | ||||
| Additional paid-in capital | ||||
| Accumulated other comprehensive loss | ||||
| Deficit | ||||
| TOTAL SHAREHOLDERS’ DEFICIENCY | ||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIENCY |
Loading...
